Skip to content
10-Q

Quarterly Report

Dova Pharmaceuticals Inc.

0001685071-19-000023

← back to feed
Filed
Aug 6, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2019 · Aug 5, 2019 28.8M sh
Capex Q2 2019 · Jun 30, 2019 $19K
Capex Q2 2019 · Jun 30, 2018 $239K
Operating Cash Flow Q2 2019 · Jun 30, 2019 −$27.87M
Operating Cash Flow Q2 2019 · Jun 30, 2018 −$23.65M
Long Term Debt Q2 2019 · Jun 30, 2019 $19.52M
Long Term Debt Q2 2019 · Dec 31, 2018 $13.94M
Short Term Debt Q2 2019 · Jun 30, 2019 $1.18M
Short Term Debt Q2 2019 · Dec 31, 2018 $6.67M
Cash And Equivalents Q2 2019 · Jun 30, 2019 $76.78M
Cash And Equivalents Q2 2019 · Dec 31, 2018 $104.57M
Stockholders Equity Q2 2019 · Jun 30, 2019 $50.81M
Stockholders Equity Q2 2019 · Mar 31, 2019 $63.29M
Stockholders Equity Q2 2019 · Dec 31, 2018 $76.36M
Stockholders Equity Q2 2019 · Jun 30, 2018 $109.72M
Stockholders Equity Q2 2019 · Mar 31, 2018 $125.1M
Stockholders Equity Q2 2019 · Dec 31, 2017 $61.18M
Current Liabilities Q2 2019 · Jun 30, 2019 $15.18M
Current Liabilities Q2 2019 · Dec 31, 2018 $19.5M
Total Liabilities Q2 2019 · Jun 30, 2019 $36.37M
Total Liabilities Q2 2019 · Dec 31, 2018 $35.81M
Current Assets Q2 2019 · Jun 30, 2019 $85.6M
Current Assets Q2 2019 · Dec 31, 2018 $111.81M
Total Assets Q2 2019 · Jun 30, 2019 $87.18M
Total Assets Q2 2019 · Dec 31, 2018 $112.17M
Rd Expense Q2 2019 · Jun 30, 2019 $4.51M
Rd Expense Q2 2019 · Jun 30, 2019 $8.59M
Rd Expense Q2 2019 · Jun 30, 2018 $4.51M
Rd Expense Q2 2019 · Jun 30, 2018 $7.92M
Net Income Q2 2019 · Jun 30, 2019 −$17.06M
Net Income Q2 2019 · Jun 30, 2019 −$33.44M
Net Income Q2 2019 · Mar 31, 2019 −$16.38M
Net Income Q2 2019 · Jun 30, 2018 −$19.66M
Net Income Q2 2019 · Jun 30, 2018 −$33.43M
Net Income Q2 2019 · Mar 31, 2018 −$13.77M
Operating Income Q2 2019 · Jun 30, 2019 −$16.93M
Operating Income Q2 2019 · Jun 30, 2019 −$33.28M
Operating Income Q2 2019 · Jun 30, 2018 −$19.01M
Operating Income Q2 2019 · Jun 30, 2018 −$32.69M
Revenue Q2 2019 · Jun 30, 2019 $3.52M
Revenue Q2 2019 · Jun 30, 2019 $7.52M
Revenue Q2 2019 · Jun 30, 2018 $4.58M
Revenue Q2 2019 · Jun 30, 2018 $4.58M